Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE

par Eastell, R., Mitlak, B. H., Wang, Y., Hu, M., Fitzpatrick, L. A., Black, D. M.
Publié dans Osteoporos Int (2019)

Forearm bone mineral density and fracture incidence in postmenopausal women with osteoporosis: results from the ACTIVExtend phase 3 trial

par Watts, N.B., Dore, R.K., Baim, S., Mitlak, B., Hattersley, G., Wang, Y., Rozental, T.D., LeBoff, M.S.
Publié dans Osteoporos Int (2020)

Tools in the assessment of sarcopenia

par Cooper, C, Fielding, R, Visser, M, van Loon, LJ, Rolland, Y, Orwoll, E, Reid, K, Boonen, S, Dere, W, Epstein, S, Mitlak, B, Tsouderos, Y, Sayer, AA, Rizzoli, R, Reginster, JY, Kanis, JA
Publié 2013

Treatment of osteoporosis in men

par Kaufman, J.-M., Reginster, J.-Y., Boonen, S., Brandi, M. L., Cooper, C., Dere, W., Devogelaer, J.-P., Diez-Perez, A., Kanis, J. A., McCloskey, E., Mitlak, B., Orwoll, E., Ringe, J.D., Weryha, G., Rizzoli, R.
Publié 2012